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2576Objective:Ventricular septal defect (VSD) is among the most common congenital heart diseases encountered in
pediatric cardiac patients. Apical muscular VSD constitutes nearly 2% of defects, which may or may not be
associated with other congenital heart defects. The purpose of our study is to present our innovative and simple
surgical technique using custom-made low-profile polytetrafluoroethylene (PTFE) single disc device for closing
multiple apical muscular and isolated apical muscular VSD.
Method: Between January 2010 and July 2013, 17 patients with isolated or multiple apical muscular VSDs with
or without associated heart diseases underwent operation at our institute. The apical VSD was closed using our
custom-made low-profile single disc polytetrafluoroethylene device. The operative technique and the technique
used to prepare the single disc device are detailed.
Results: Seventeen patients of ages ranging from 3 months to 7 years underwent operation over 3 years. One
8-month-old patient with transposition of the great arteries with multiple VSDs died after 35 days due to severe
pulmonary artery hypertension and sepsis. Another newborn infant with infracardiac total anomalous pulmonary
venous connection with a 4-mm apical VSD also died after 3 days because this VSD could not be identified. All
other patients are doing well on follow-up.
Conclusions: The technique described by us has the advantage of apical VSD closure through the left
ventricle without left ventriculotomy. Our technique is simple and cost-effective. (J Thorac Cardiovasc Surg
2014;148:2576-9)Ventricular septal defect (VSD) is a common congenital
heart disease encountered in pediatric cardiac practice;
nearly 2% of all VSDs are apical. They may be isolated
or multiple, although apical VSDs are rarely in isolation,
and they are usually associated with 1 or more other
congenital heart diseases. Although indications and tech-
niques for closing different types of VSDs surgically and
by interventions are by and large standardized, there has
been a rapid increase in incidence of catheter-based and per-
ventricular closure of muscular VSD. Because the tech-
nique for closing apical muscular VSD is still a matter of
debate, we present our innovative and simple surgical tech-
nique for closing apical VSD using our cost-effective,
custom-made low-profile single disc polytetrafluoroethy-
lene (PTFE) device.e Department of Cardiovascular and Thoracic Surgery, U. N. Mehta Institute
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The Journal of Thoracic and Cardiovascular SurCASE DETAILS
Seventeen patients with multiple and isolated apical VSD
with or without associated heart defects underwent opera-
tion at our institution between January 2010 and
July 2013. All patients were diagnosed on the basis of
clinical history, examination, electrocardiography, and
2-dimensional echocardiography. Cardiac catheterization
was done to assess the operability and, if needed, angiog-
raphy to confirm the anatomy of the defects. The hospital
ethics committee approved the study protocol. Written con-
sent was obtained from both parents, who were informed
about the nature, the advantages, and the disadvantages of
the procedure.MATERIAL AND METHOD
The disc device (Figure 1, A and B) was prepared before surgery in the
operating room.
The device has 2 parts: a disc and a shaft. The circular disc is made from
2 patches: 1 patch of expanded PTFE (ePTFE) (Gor-Tex patch,W. L. Gore,
Flagstaff, Ariz) of thickness 0.6 mm and another patch of PTFE felt (CR
Bard, Inc, Delran, NJ) of thickness 0.8 mm that are sutured to each other.
The total thickness of the disc is nearly 1.4 mm and its diameter is
nearly twice the maximum diameter of the VSD. The shaft is also made
from a 2- to 2.5-cm long ePTFE tube (CR Bard, Inc, Delran, NJ) of the
same diameter as the maximum size of the VSD. The graft is sutured to
the center of the disc in an end-to-side fashion on the Teflon felt side (septal
surface of device) using continuous monofilament polypropylene suture
and is reinforced at 2 to 3 points. Two extra disc devices with graft sizes
1 mm above and below the required size of the device are also kept ready.gery c December 2014
Abbreviations and Acronyms
CPB ¼ cardiopulmonary bypass
ePTFE ¼ expanded polytetrafluoroethylene
LV ¼ left ventricular
PTFE ¼ polytetrafluoroethylene
TEE ¼ transesophageal echocardiography
VSD ¼ ventricular septal defect
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ping between the 2 discs.
Surgical Technique
Intraoperative transesophageal echocardiography (TEE) and/or trans-
thoracic echocardiography was performed in all patients to confirm the
size, number, and position of VSD in relation to the moderator band
(Figure 2). The VSD size was measured in 4-chamber and long axis
view, the larger of the 2 values was considered for device selection.
After cardioplegic arrest and right atriotomy, the interatrial septum was
widely opened. In all cases, a right angle forcep was used to gently probe
the apical part of the ventricular septum at the expected site of the apical
VSD (Figure 2, A). This angle forcep was passed through the defect and
an assistant retracted the mitral valve through the interatrial septum
(Figure 2, B). After confirming its position through the defect, the device
was caught and held with the help of a right angle forcep (Figure 2, C)
and its shaft was gently pulled through the ventricular septum (Figure 2,
D), taking care to avoid injuring the neighboring anterior papillary muscle
or the moderator band. An illuminating dental mirror was used to confirm
the latter and accurate positioning of the device (Figure 2, F). The shaft of
the devicewas sutured at its base to the septal muscles adjacent to the VSD/
moderator band using 2 interrupted pledgeted polypropylene sutures clos-
ing the lumen of the graft (Figure 2, E). The remaining portion of the shaft
was excised. In 1 patient 2 disc devices were used because the VSD was 16
mm in size with 2 openings in front and behind the moderator band. The
procedure takes approximately 15 to 20 minutes.
Associated cardiac defects were corrected in the usual fashion and after
weaning from cardiopulmonary bypass (CPB), TEE/epicardial echocardi-
ography was routinely performed to confirm adequate repair. Routine
blood samples were drawn from right atrium and pulmonary artery and ox-
ygen saturation was checked in all patients, keeping the fractional inspired
oxygen at 50%. Step-up>5% was considered significant.RESULTS
An 8-month-old patient with transposition of the great ar-
teries with multiple VSDs died after 35 days due to severe
pulmonary artery hypertension and sepsis. However, in a
2.7-kg patient with infracardiac total anomalous pulmonary
venous connection the apical VSD could not be identified.
This patient later died on the third postoperative day due
to severe pulmonary artery hypertension. Occasionally we
found tiny turbulence between the disc and the septum
and occasionally we noticed a tiny leak around the shunt
graft during the immediate postoperative period without
significant left to right shunt, which usually disappeared
in a day or 2. All had step-up of<5%, except in a patient
who had multiple tiny residual VSD who underwent pulmo-
nary artery debanding and multiple VSD closure withThe Journal of Thoracic and Carstep-up of 8.2% for which nothingwas done because the pa-
tient was hemodynamically stable. CPBwas reinstituted in 2
patients. In 1 patient who had moderate mitral regurgitation
on TEE, the oversize disc was flattering and was interfering
with the closure of mitral valve, so the disc was reduced in
size. In that patient the diameter of the disc was nearly 2.5
times the diameter of the VSD. In another patient CPB
was reinstituted because there was an additional undiag-
nosed posterior muscular VSD. Both patients recovered
uneventfully. No patient had heart block arrhythmia, hemo-
lysis, or any neurologic complications. Median intensive
care unit staywas 4 days (range, 2-35 days).Median hospital
staywas 11 days (range, 10-35 days).Median follow-upwas
12 months (range, 6-30 months) and was complete. At last
follow-up, no patient has required reintervention or devel-
oped a device-related complication. Follow-up echocardio-
grams reveal no residual left-to-right shunt.
DISCUSSION
VSD is the most common congenital heart disease
encountered in pediatric cardiology clinics. Nearly 2% of
VSDs are apical; they may be single or multiple. Apical
VSD may be isolated but is usually associated with some
other congenital heart diseases. Various standard surgical
techniques and interventions are available to close different
types of VSD. Technique for closure of apical VSD is still a
subject of debate. There is a rapid increase in percutaneous
and perventricular closure of muscular VSD. The anatomy
of apical septum and echocardiographic assessment was ex-
plained in detail by Kumar and colleagues.1 Because the
apical septum is the most distal part of the septum and it
has trabeculations on the right ventricular side, it is difficult
to visualize the margins of the defect clearly from the right
ventricular aspect of the septum through the tricuspid valve.
The space at the apex is also limited, hence it is difficult to
close the defect from the right atrium.2,3
The technique of closing an apical VSD through left ven-
triculotomy was described by Aaron and colleagues.4 The
identification of apical VSD through left ventriculotomy
is easy because the left ventricular side of the septum is
smooth with no papillary muscle attachment. An apical
VSD usually has a solitary opening on the left ventricular
(LV) side of the septum. Left ventriculotomy carries the
risk of late ventricular aneurysm formation, myocardial
dysfunction, and arrhythmias.5 Right ventriculotomy is
less dangerous but it may be difficult to find the true margins
of the defect between the coarse trabeculations, especially
in patients who have pulmonary stenosis.
Earlier we were also closing apical septal defects through
right ventriculotomy. Right ventriculotomymay increase the
risk of postoperative right ventricular dysfunction,6 espe-
cially when apical VSD is associated with conditions like
tetralogy of Fallot, transposition of the great arteries, VSD
with pulmonary stenosis, and multiple VSD with singlediovascular Surgery c Volume 148, Number 6 2577
FIGURE 1. A, Photograph of disc device. B, Diagram of disc device. ePTFE, Expanded polytetrafluoroethylene; PTFE, polytetrafluoroethylene.
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wich technique for closing trabecular VSD in 11 patients.
However 3 of their patients had significant residual shunt.
We believe that it is difficult to stitch at the apical portion
of the septum. The only advantage we see of our technique
is that the shaft of the device obliterates the VSD and thus
the incidence of residual shunt is least with our technique.
Initial attempts at intraoperative device closure of
muscular VSD in patients in whom percutaneous closure
was contraindicated (eg, small infants) had unsatisfactory
results with mortality and failure rates as high as 14% to
25% and 20% to 40%, respectively.8-11
Hybrid procedures and perventricular device closures
are increasingly gaining popularity in closing muscularFIGURE 2. A, A right angle forceps probed into the VSD. B, Position confirm
holds the shaft of the device. D, The shaft of the device is pulled through the VSD
device fixed to the RV side of the septum obliterating the graft. F, Position of V
2578 The Journal of Thoracic and Cardiovascular SurVSDs, with good results in isolated VSD as well as in
patients with associated congenital heart defects.12 Per-
ventricular device closure of VSD has its own limitations,
including some anatomical variations of muscular defects
like high posterior muscular defects, distal apical defects,
and misaligned defects where it is difficult to get access
and there is no space for deployment of the right ventricle
side of the disc,12,13 which is not a limitation of our
device. Perventricular VSD closure is also associated
with ventricular arrhythmias, LV pseudoaneurysm
formation,14 LV dysfunction,16 incomplete right ventricle
disc expansion with the screw of the disc protruding into
the pericardium,12,15 and hemolysis in the presence of
residual shunt.13ed while an assistant retracts the mitral valve. C, Right angle forceps now
avoiding injury to mitral subvalvular apparatus andmoderator band. E, The
SD confirmed with the help of dental mirrors.
gery c December 2014
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available for easily closing atrial septal defects using the
transcatheter technique. The PTFE is also used to close
the VSD in operating theaters. We combined the PTFE
and ePTFE—both of which are readily available in oper-
ating theaters—to prepare our indigenous device. The
PTFE (Teflon felt) material is soft and spongy, which pro-
vides a cushion effect on the septal surface of the device.
The device works in 3 ways for prevention of left to right
shunt across the VSD. First, the graft itself obliterates the
VSD, because the size of the graft is the same as that of
VSD. Second, the disc will also cover the LV side of septum
as well as the surrounding area of the VSD. Third, the right
ventricular side of the graft is closed with pledgeted stitches
with surrounding septal muscles; hence any residual left to
right shunt cannot occur around the graft. Multiple apical
VSDs usually have a single opening on the left side septum,
so closure of apical VSD will also close all other apical
VSDs. If any additional VSD is present in the vicinity of
the apical VSD, it will also be covered by the disc. The
LV surface is smooth and does not have any attachment
of papillary muscles so the disc gets firmly adhered to the
LV side of the septum. The high pressure in the LV also
keeps the disc in its position. Only if the diameter of the
disc is more than twice the diameter of the VSD may we
see the flattering movement of the disc, as noticed in 1 of
our patients. Our disc device being low profile does not
interfere with the geometry/contraction of the LV.
Our custom-made device can be tailored and prepared
in-house in 10 minutes. Finally, the cost of our single disc
device is $100, whereas the cost of a commercially avail-
able device is nearly $1300. The use of our device would
therefore drastically bring down the expense of the total
procedure and make it significantly more affordable for
patients of lower economic strata.CONCLUSIONS
The technique we described has the advantage of apical
VSD closure through the LV without left ventriculotomy.
Our technique is simple and cost-effective.
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